<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2026.1749597</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Ferroptosis-mediated intestinal decolonization of <italic>Klebsiella pneumoniae</italic> using Fe/PPy nanomaterials under near-infrared light</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Zhang</surname>
<given-names>Xu</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn0009"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3286068"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Yan</surname>
<given-names>Zelin</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn0009"><sup>&#x2020;</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Binna</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shi</surname>
<given-names>Siyu</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Yuchen</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Yanyan</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gu</surname>
<given-names>Danxia</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/681040"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tang</surname>
<given-names>Huqiang</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhang</surname>
<given-names>Rong</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/258478"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Department of Clinical Laboratory, The Second Affiliated Hospital Zhejiang, University School of Medicine</institution>, <city>Zhejiang</city>, <country country="cn">China</country></aff>
<aff id="aff2"><label>2</label><institution>The Second School of Clinical Medicine, Anhui Medical University</institution>, <city>Hefei</city>, <state>Anhui</state>, <country country="cn">China</country></aff>
<aff id="aff3"><label>3</label><institution>Centre of Laboratory Medicine, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College</institution>, <city>Hangzhou</city>, <country country="cn">China</country></aff>
<author-notes>
<corresp id="c001"><label>&#x002A;</label>Correspondence: Rong Zhang, <email xlink:href="mailto:zhang-rong@zju.edu.cn">zhang-rong@zju.edu.cn</email></corresp>
<fn fn-type="equal" id="fn0009"><label>&#x2020;</label><p>These authors have contributed equally to this work and share first authorship</p></fn>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-20">
<day>20</day>
<month>02</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>17</volume>
<elocation-id>1749597</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>11</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>17</day>
<month>01</month>
<year>2026</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>02</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2026 Zhang, Yan, Zhang, Shi, Wu, Zhang, Gu, Tang and Zhang.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Zhang, Yan, Zhang, Shi, Wu, Zhang, Gu, Tang and Zhang</copyright-holder>
<license>
<ali:license_ref start_date="2026-02-20">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>Klebsiella pneumoniae (KP) is a Gram-negative bacterium with a thick capsule that confers natural drug resistance, making it a common opportunistic pathogen. In recent years, the spread of <italic>hypervirulent Klebsiella pneumoniae</italic> (hvKP) and carbapenem-resistant Klebsiella pneumoniae (CR-KP) strains has created major treatment challenges. Among these, of particular concern is <italic>carbapenem-resistant hypervirulent Klebsiella pneumoniae</italic> (CR-hvKP), which combines both hypervirulence and carbapenem resistance. This strain can persistently colonize the gut, facilitating resistance gene spread and causing bacterial translocation with subsequent infections. CR-hvKP has now become a key pathogen in both hospital and community settings. Traditional antibiotic treatments often lead to the emergence of bacterial resistance, necessitating the development of novel antimicrobial strategies.</p>
</sec>
<sec>
<title>Methods</title>
<p>This study introduces an iron-polypyrrole nanocomposite (Fe/PPy) designed to leverage an innovative mechanism of ferroptosis-induced bacterial killing. The nanomaterial possesses intrinsic Fenton reaction activity. Moreover, its photothermal conversion efficiency exceeds 85%. Under 1,064 nm near-infrared (NIR) light, its photothermal effect significantly enhances the Fenton reaction efficiency, thereby effectively catalyzing the conversion of bacterial endogenous H&#x2082;O&#x2082; into reactive oxygen species (ROS), thereby inducing bacterial lipid peroxidation and achieving targeted bacterial killing via the ferroptosis pathway.</p>
</sec>
<sec>
<title>Results</title>
<p>The excellent tissue penetration of 1,064 nm NIR light enables this material to act precisely on deep-seated infectious lesions, achieving <italic>in vivo</italic> antibacterial efficacy. Experimental results demonstrate that Fe/PPy nanomaterials exhibit high antimicrobial efficacy and safety against KP without readily inducing bacterial resistance.</p>
</sec>
<sec>
<title>Discussion</title>
<p>This study provides a novel nanodrug design approach for the clinical treatment of KP infections, offering significant translational potential in the field of anti-infective therapy.</p>
</sec>
</abstract>
<kwd-group>
<kwd>ferroptosis</kwd>
<kwd>intestinal decolonization</kwd>
<kwd><italic>Klebsiella pneumoniae</italic></kwd>
<kwd>near-infrared light</kwd>
<kwd>reactive oxygen species</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This work was supported by the National Key Research and Development Program of China (no. 2022YFD1800400).</funding-statement>
</funding-group>
<counts>
<fig-count count="6"/>
<table-count count="1"/>
<equation-count count="1"/>
<ref-count count="40"/>
<page-count count="11"/>
<word-count count="7261"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Antimicrobials, Resistance and Chemotherapy</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<label>1</label>
<title>Introduction</title>
<p><italic>Carbapenem-Resistantklebsiella pneumoniae</italic> (CR-KP) and <italic>Hypervirulentklebsiella pneumoniae</italic> (hvKP) are significant public health concerns due to their association with high mortality rates (<xref ref-type="bibr" rid="ref10">Fang et al., 2022</xref>; <xref ref-type="bibr" rid="ref31">Russo and Marr, 2019</xref>; <xref ref-type="bibr" rid="ref33">Wang Q. et al., 2024</xref>; <xref ref-type="bibr" rid="ref38">Yang et al., 2022</xref>). Sequence type ST11 is the predominant clone, linked to infections with a notably high in-hospital mortality rate of 33. 5% (<xref ref-type="bibr" rid="ref31">Russo and Marr, 2019</xref>). Meanwhile, ST23 hvKp organisms have acquired various antimicrobial resistance (AMR) genes but have not lost key virulence-associated genes, maintaining their strong pathogenicity (<xref ref-type="bibr" rid="ref4">Chang et al., 2022</xref>). CR-KP strains exhibit resistance to carbapenem antibiotics, limiting effective treatment options and leading to increased patient mortality (<xref ref-type="bibr" rid="ref20">Jia et al., 2024</xref>; <xref ref-type="bibr" rid="ref30">Pu et al., 2023</xref>; <xref ref-type="bibr" rid="ref30">Pu et al., 2023</xref>; <xref ref-type="bibr" rid="ref37">Yang et al., 2021</xref>) hvKP strains possess enhanced virulence factors, resulting in severe infections and elevated mortality rates. The emergence of these pathogenic strains underscores the urgent need for novel antimicrobial strategies to combat these life-threatening infections (<xref ref-type="bibr" rid="ref34">Wang R. et al., 2024</xref>). In clinical practice, when KP colonizes the intestine, it can spread to other parts of the body through the bloodstream, causing systemic infections such as pneumonia and sepsis (<xref ref-type="bibr" rid="ref6">Choby et al., 2020</xref>; <xref ref-type="bibr" rid="ref39">Zhang Q. et al., 2023</xref>; <xref ref-type="bibr" rid="ref29">Osbelt et al., 2021</xref>; <xref ref-type="bibr" rid="ref35">Xie et al., 2025</xref>). Traditional approaches primarily rely on antibiotics to decolonize the intestine; however, the rapid evolution of hvKP and the widespread prevalence ofCR-KP, along with the persistent biofilm formation by these bacteria, significantly reduce the penetration of drugs (<xref ref-type="bibr" rid="ref28">Miller and Arias, 2024</xref>; <xref ref-type="bibr" rid="ref9">Eller et al., 2021</xref>; <xref ref-type="bibr" rid="ref2">Bengoechea and Sa Pessoa, 2019</xref>; <xref ref-type="bibr" rid="ref32">Siu et al., 2012</xref>). These factors present certain limitations in clinical treatment. Additionally, antibiotic therapy itself may disrupt the intestinal barrier, inadvertently promoting the intestinal translocation of CR-KP (<xref ref-type="bibr" rid="ref14">Gu et al., 2018</xref>). In an ICU of a tertiary hospital in China, a KP strain with dual resistance to carbapenems and tigecycline, which had been persistently colonizing the intestines of patients, posed a considerable challenge for clinical management (<xref ref-type="bibr" rid="ref25">Liu et al., 2022</xref>). Meanwhile, alternative therapies, such as probiotics, can be employed to modulate the intestinal microbiota, but their effectiveness in eliminating resistant bacterial colonization remains limited (<xref ref-type="bibr" rid="ref10">Fang et al., 2022</xref>; <xref ref-type="bibr" rid="ref16">Hu et al., 2024</xref>; <xref ref-type="bibr" rid="ref5">Chen et al., 2021</xref>). These challenges underscore the urgent need for innovative therapeutic strategies that bypass conventional resistance mechanisms while maintaining efficacy against CR-KP (<xref ref-type="bibr" rid="ref16">Hu et al., 2024</xref>).</p>
<p>Nanomedicine has emerged as a revolutionary frontier in antimicrobial therapy, offering a versatile platform for precise targeted treatment and multimodal synergistic interventions (<xref ref-type="bibr" rid="ref40">Zhang X. et al., 2023</xref>). Drawing from our group&#x2019;s previous oncology research, we developed an ultrasmall Fe/PPy nanomaterialscapable of selectively inducing tumor cell death throughferroptosis (<xref ref-type="bibr" rid="ref24">Li et al., 2021</xref>). This nanomaterials exhibits dual functional mechanisms: (i) As a photothermal conversion agent, it achieves a NIR light-to-heat conversion efficiency exceeding 85%, enabling spatiotemporally controlled thermal effects in the range of 42&#x2013;50&#x202F;&#x00B0;C, effectively ablating tumor cells;(ii) Owing to its iron-rich nature, this component continuously generates ROS via the Fenton reaction, significantly amplifying oxidative stress levels within the tumor microenvironment (<xref ref-type="bibr" rid="ref40">Zhang X. et al., 2023</xref>).</p>
<p>Although Fe/PPy demonstrated enhanced antibacterial activity against <italic>Klebsiella pneumoniae</italic> in this study, this effect does not imply absolute species-specific killing. Instead, the observed antibacterial behavior is more appropriately described as a preferential or potentially selective effect. Previous studies have shown that different bacterial species exhibit substantial differences in membrane composition, surface charge distribution, and outer membrane architecture (<xref ref-type="bibr" rid="ref27">Makvandi et al., 2023</xref>; <xref ref-type="bibr" rid="ref22">Kim et al., 2018</xref>). These physicochemical differences may influence nanoparticle adsorption efficiency as well as the local accumulation and bioavailability of Fe<sup>3+</sup> ions released from the Fe/PPy system, thereby contributing to differential antibacterial outcomes among bacterial species.</p>
<p>This study is based on the presence of endogenous hydrogen peroxide (H&#x2082;O&#x2082;) in bacteria, a key feature of microbial redox metabolism. Endogenous H&#x2082;O&#x2082; primarily arises from the incomplete reduction of oxygen during cellular metabolism. As a common byproduct of bacterial energy metabolism, it is widely present across diverse bacterial taxa and is not unique to any single species (<xref ref-type="bibr" rid="ref18">Imlay, 2008</xref>; <xref ref-type="bibr" rid="ref19">Imlay, 2013</xref>). Given the role of endogenousH&#x2082;O&#x2082; in bacteria, we explored the potential antibacterial mechanism of Fe/PPy nanomaterials to understand how to utilize these reactive substances for catalytic effects. Importantly, we recognize that Fe/PPy nanomaterials may not directly penetrate the bacterial cell wall to exert their antibacterial action (<xref ref-type="bibr" rid="ref36">Xue et al., 2023</xref>). The mechanism is more likely as follows: Fe/PPy nanoparticles first adsorb onto the bacterial surface through electrostatic interactions, releasing Fe<sup>3+</sup> upon irradiation with NIR light; subsequently, the Fe<sup>3+</sup> enters the bacterial interior, where it reacts with endogenous H&#x2082;O&#x2082;in a Fenton reaction, catalyzing the generation of hydroxyl radicals (&#x2022;OH) and thus inducing bacterial ferroptosis (<xref ref-type="bibr" rid="ref15">Guerrieri et al., 2021</xref>; <xref ref-type="bibr" rid="ref11">Fromain, 2023</xref>). Recent investigations reveal that Fe/PPy&#x2019;s ferroptosis-inducing capability extends beyond eukaryotic cells (<xref ref-type="bibr" rid="ref5">Chen et al., 2021</xref>; <xref ref-type="bibr" rid="ref8">Dixon et al., 2012</xref>; <xref ref-type="bibr" rid="ref13">Gan et al., 2023</xref>). When repurposed for bacterial eradication, the nanomaterial triggers iron dyshomeostasis and lipid peroxidation cascades in KP, effectively inducing bacterial ferroptosis. This bactericidal mechanism operates independently of traditional antibiotic targets, thereby circumventing existing resistance pathways (<xref ref-type="bibr" rid="ref3">Blair et al., 2015</xref>). Furthermore, the concomitant photothermal effect disrupts biofilm integrity through localized hyperthermia, sensitizing persister cells to ferroptotic stress (<xref ref-type="bibr" rid="ref12">Fulaz et al., 2019</xref>). Such multimodal synergy&#x2014;combining physical biofilm disruption, metabolic perturbation via glucose oxidase (GOX)-mediated starvation, and ferroptosis induction&#x2014;represents a paradigm shift in antimicrobial strategy (<xref ref-type="bibr" rid="ref17">Huo et al., 2025</xref>; <xref ref-type="bibr" rid="ref1">Bankar et al., 2009</xref>; <xref ref-type="bibr" rid="ref21">Jiang et al., 2021</xref>). Notably, recent studies have demonstrated that nanomaterials can effectively eradicate bacteria through the ferroptosis pathway (<xref ref-type="bibr" rid="ref26">Liu et al., 2023</xref>; <xref ref-type="bibr" rid="ref7">Cui et al., 2023</xref>; <xref ref-type="bibr" rid="ref7">Cui et al., 2023</xref>). Inspired by these findings, we engineered an established cancer therapeutic nanoplatform for antimicrobial applications, leveraging its intrinsic ferroptosis-inducing capability while incorporating photothermal synergistic effects (<xref ref-type="bibr" rid="ref7">Cui et al., 2023</xref>). This work not only unveils a previously unrecognized bacterial ferroptosis pathway but also establishes a blueprint for cross-disciplinary therapeutic innovation. Fe/PPy can concurrently address biofilms, virulence factors of hypervirulent <italic>Klebsiella pneumoniae</italic>, and multiple resistance mechanisms, making it a promising translational candidate in precision nanomedicine and offering important implications for the treatment of recalcitrant bacterial infections.</p>
</sec>
<sec sec-type="methods" id="sec11">
<label>2</label>
<title>Methods</title>
<sec id="sec12">
<label>2.1</label>
<title>Materials</title>
<p><italic>Synthesis of Fe&#x2083;O&#x2084; Nanoparticles (NPs):</italic> First, FeCl&#x2083; (324&#x202F;mg, 2.0&#x202F;mmol) was dissolved in diethylene glycol (DEG, 20&#x202F;mL) under vigorous stirring until a homogeneous solution was obtained. Subsequently, sodium citrate (206&#x202F;mg, 0. 8&#x202F;mmol) and sodium acetate (NaOAc, 492&#x202F;mg, 6.0&#x202F;mmol) were sequentially added, with continuous stirring until complete dissolution. The resulting mixture was then transferred into a polytetrafluoroethylene-lined autoclave and subjected to hydrothermal treatment at 210&#x202F;&#x00B0;C for 10&#x202F;h. After cooling to room temperature, the obtained product was thoroughly washed with deionized water and ethanol several times to remove residual reactants. Finally, small-sized magnetic Fe&#x2083;O&#x2084; NPs were successfully obtained.</p>
<p><italic>Synthesis of Fe/PPy NPs:</italic> Fe&#x2083;O&#x2084; NPs (5.6&#x202F;mg), prepared as described above, were dispersed in a polyvinylpyrrolidone (PVP, 5&#x202F;mL) solution and ultrasonicated to achieve uniform dispersion. Subsequently, N, N-dimethylformamide (DMF, 200&#x202F;&#x03BC;L), pyridine (py, 5&#x202F;mL), and carboxylated pyridine (py-COOH, 10&#x202F;mg) were added, followed by ultrasonic treatment to facilitate dissolution and homogeneous mixing. Hydrochloric acid solution (HCl, 200&#x202F;&#x03BC;L, 2&#x202F;mol/L) was then introduced into the reaction system, which was maintained at 37&#x202F;&#x00B0;C for 24&#x202F;h. Upon completion of the reaction, the product was purified through alternating ethanol and water washes, collected by centrifugation, and finally redispersed in ultrapure water to yield Fe/PPy NPs.</p>
<p><italic>Monitoring of extracellular photothermal effect:</italic> Fe/PPy aqueous solutions with different concentrations (25, 50, 75, and 100&#x202F;ppm) were first prepared. The samples were then irradiated with a NIR light at a wavelength of 1,064&#x202F;nm (2&#x202F;W/cm<sup>2</sup>), while a high-precision thermocouple thermometer was employed to record real-time temperature variations of the solution. This approach systematically evaluated the photothermal conversion performance of the material.</p>
<p><italic>Detection of &#x00B7;OH:</italic> To quantitatively detect the generation of &#x00B7;OH during the reaction, MBwas used as a specific indicator. The detection principle is based on the ability of &#x00B7;OH to selectively oxidize and degrade MB molecules, resulting in a gradual decrease in the intensity of the characteristic absorption peak as the reaction progresses. First, Fe/PPy material, MB solution (200&#x202F;&#x03BC;M), and hydrogen peroxide (H&#x2082;O&#x2082;, 10&#x202F;mM) were mixed in the predetermined ratio and irradiated with NIR for 1,064&#x202F;nm (2&#x202F;W/cm<sup>2</sup>, 10&#x202F;min). After the reaction, the full spectrum was scanned using a UV&#x2013;Vis spectrophotometer, and the absorbance at the characteristic MB absorption wavelength (660&#x202F;nm) was recorded, enabling the detection of hydroxyl radicals.</p>
<p><italic>Evaluation of Fe/PPy:</italic> To systematically evaluate the antimicrobial performance of Fe/PPy, this study employed the plate colony counting method and Syto9/PI live/dead staining assay to test the 22-ZR and HvKP4 bacterial strains. The frozen bacterial strains were first revived and streaked onto LB agar plates, followed by incubation at 37&#x202F;&#x00B0;C overnight. Single colonies were then picked and inoculated into LB liquid medium, which was cultured at 37&#x202F;&#x00B0;C with shaking at 200&#x202F;rpm until the logarithmic growth phase was reached. The bacterial suspension was adjusted to a concentration of 1&#x202F;&#x00D7;&#x202F;10<sup>7</sup>&#x202F;CFU/mL using PBS buffer. For the antimicrobial experiment, the bacterial suspension was co-cultured with Fe/PPy material and subjected to NIR treatment for 8&#x202F;min (1,064&#x202F;nm, 2&#x202F;W/cm<sup>2</sup>). The treated bacterial suspension was diluted 10 (<xref ref-type="bibr" rid="ref33">Wang Q. et al., 2024</xref>)-fold and then plated onto LB agar plates, and incubated at 37&#x202F;&#x00B0;C for 24&#x202F;h. CFU were counted to quantitatively evaluate the antimicrobial effect. Additionally, the Syto9/PI dual staining kit was used to further analyze bacterial viability. After treatment, the bacterial suspension was centrifuged at 4000&#x202F;rpm for 10&#x202F;min, and the pellet was resuspended in Syto9/PI mixed staining solution and incubated in the dark for 10&#x202F;min. Finally, a confocal microscope was used to observe and record the distribution of live bacteria (green fluorescence) and dead bacteria (red fluorescence), providing a visual representation of the antimicrobial performance of the material.</p>
<p><italic>In vitro antibiofilm properties of Fe/PPy:</italic> To comprehensively evaluate the inhibitory effect of Fe/PPy on bacterial biofilms, this study combined crystal violet staining quantification with SEMmorphology observation. Initially, the bacterial strains were cultured statically for 48&#x202F;h to allow for the formation of mature biofilms. After co-culturing with Fe/PPy material, the biofilms were subjected to NIR treatment for 8&#x202F;min (1,064&#x202F;nm, 2&#x202F;W/cm<sup>2</sup>). The supernatant was then removed, and the biofilms were stained with 0. 1% crystal violet solution for 30&#x202F;min to assess the degree of biofilm disruption. In addition, to visually observe the structural changes in the biofilm, the treated samples were centrifuged at 4000&#x202F;rpm for 10&#x202F;min. The pellets were fixed overnight at 4&#x202F;&#x00B0;C with 2. 5% glutaraldehyde, followed by dehydration through a gradient ethanol series (30, 50, 70, 80, 90, 95, and 100% ethanol, each for 15&#x202F;min). After critical point drying and gold sputtering, the samples were examined using a field-emission scanning electron microscope at various magnifications. This allowed for the observation of the biofilm&#x2019;s three-dimensional structure and surface morphology, providing a systematic analysis of the disruption caused by Fe/PPy on the biofilm.</p>
<p><italic>Intracellular ROS detection:</italic> DCFH-DA fluorescence probe was used to detect intracellular ROS levels in bacteria. This probe specifically reacts with &#x00B7;OH, producing green fluorescence. Initially, the bacterial suspension was co-cultured with Fe/PPy material for 4&#x202F;h, followed by NIR irradiation for 8&#x202F;min. After treatment, the bacterial suspension was centrifuged at 4000&#x202F;rpm for 10&#x202F;min to collect the bacterial cells. The cells were then resuspended and incubated in DCFH-DA fluorescence staining solution in the dark for 30&#x202F;min. After staining, the bacteria were washed with PBS buffer to remove any unbound dye. Finally, a confocal microscope was used to observe and record the intensity of the green fluorescence within the bacteria, which serves as an indicator of intracellular ROS generation.</p>
<p><italic>Measurement of lipid peroxidation:</italic> Lipid peroxidation in bacterial cells was evaluated by quantifying MDA levels using a commercial MDA assay kit. Briefly, hvKP4 and 22ZR-42 were subjected to different treatments (Control, NIR, Fe/PPy, Fe/PPy&#x202F;+&#x202F;NIR, and Fe/PPy&#x202F;+&#x202F;NIR&#x202F;+&#x202F;DFO). After treatment, bacterial samples were collected and lysed, and equal volumes of the lysates were mixed with MDA working solution. The mixtures were heated at 100&#x202F;&#x00B0;C for 15&#x202F;min to allow the thiobarbituric acid (TBA) reaction to proceed. After cooling to room temperature, the samples were centrifuged, and the supernatants were transferred to a 96-well plate. Absorbance was measured at 532&#x202F;nm using a microplate reader. MDA levels were calculated based on a standard curve and normalized to the total protein content of each sample.</p>
<p><italic>Hemolysis assay: H</italic>emolysis assays were performed using EDTA-anticoagulated whole blood from C57BL/6 female mice. Female mice were anesthetized by intraperitoneal administration of tribromoethanol (250&#x202F;mg/kg), followed by blood collection via the enucleation method. The blood samples were centrifuged at 3000&#x202F;rpm for 5&#x202F;min, and the supernatant (containing serum, platelets, and the white blood cell layer) was discarded. The remaining red blood cells (RBCs) were washed three times with PBS buffer and finally resuspended to prepare a 4% RBC suspension. The experiment included a negative control (PBS) and a positive control (Water). These controls, along with different concentrations of Fe/PPy nanomaterials, were co-incubated with the RBC suspension for 24&#x202F;h at 37&#x202F;&#x00B0;C under 5% CO&#x2082; conditions. After incubation, the samples were centrifuged at 3000&#x202F;rpm for 5&#x202F;min, and the supernatant was collected. The absorbance of the supernatant was measured at 576&#x202F;nm using a microplate reader. The hemolysis rate was calculated using the following formula:</p><disp-formula id="E1">
<mml:math id="M1">
<mml:mtable columnalign="left" displaystyle="true">
<mml:mtr>
<mml:mtd>
<mml:mtext>Hemolysis rate</mml:mtext>
<mml:mspace width="0.33em"/>
<mml:mo stretchy="true">(</mml:mo>
<mml:mo>%</mml:mo>
<mml:mo stretchy="true">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:mo stretchy="true">[</mml:mo>
<mml:mo stretchy="true">(</mml:mo>
<mml:msub>
<mml:mi>OD</mml:mi>
<mml:mn>576</mml:mn>
</mml:msub>
<mml:mtext>sample</mml:mtext>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>OD</mml:mi>
<mml:mn>576</mml:mn>
</mml:msub>
<mml:mtext>negative control</mml:mtext>
<mml:mo stretchy="true">)</mml:mo>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
<mml:mo>/</mml:mo>
<mml:mo stretchy="true">(</mml:mo>
<mml:msub>
<mml:mi>OD</mml:mi>
<mml:mn>576</mml:mn>
</mml:msub>
<mml:mtext>positive control</mml:mtext>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>OD</mml:mi>
<mml:mn>576</mml:mn>
</mml:msub>
<mml:mtext>negative control</mml:mtext>
<mml:mo stretchy="true">)</mml:mo>
<mml:mo stretchy="true">]</mml:mo>
<mml:mo>&#x00D7;</mml:mo>
<mml:mn>100</mml:mn>
<mml:mo>%</mml:mo>
</mml:mtd>
</mml:mtr>
</mml:mtable>
</mml:math>
</disp-formula>
<p><italic>Complete blood count and blood biochemical analysis: B</italic>lood samples were collected from C57BL/6 female mice on days 1 and 7 post-administration using EDTA- and heparin-anticoagulated tubes. Female mice were anesthetized by intraperitoneal administration of tribromoethanol (250&#x202F;mg/kg), and blood collection via the enucleation method. EDTA-anticoagulated blood was analyzed using an automated hematology analyzer for complete blood count (CBC). Heparin-anticoagulated blood was centrifuged at 3000&#x202F;rpm for 5&#x202F;min to separate plasma, which was then used for biochemical analysis.</p>
<p><italic>In vivo De-Colonization effect evaluation:</italic> C57BL/6 female mice were used to establish an intestinal colonization model. Bacterial suspensions in the logarithmic growth phase (cultured in LB medium) were adjusted to 1&#x202F;&#x00D7;&#x202F;10<sup>7</sup>&#x202F;CFU/mL, and 100&#x202F;&#x03BC;L was administered via oral gavage. After successful colonization, Fe/PPy nanomaterials were orally administered for intervention, followed by NIR irradiation of the abdominal region after 4&#x202F;h (1,064&#x202F;nm, 2&#x202F;W/cm<sup>2</sup>, 8&#x202F;min). After 24&#x202F;h of intervention, fecal samples were collected for 16S rRNA sequencing analysis to assess gut microbiota changes. The female mice were subsequently euthanized by cervical dislocation, and the heart, liver, spleen, lungs, kidneys, and intestinal tissues were harvested for hematoxylin&#x2013;eosin (H&#x0026;E) staining and pathological evaluation.</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="sec2">
<label>3</label>
<title>Results and discussion</title>
<sec id="sec3">
<label>3.1</label>
<title>Antimicrobial susceptibility profiles of HVKP4 and 22ZR-42</title>
<p>The antimicrobial susceptibility testing results (<xref ref-type="table" rid="tab1">Table 1</xref> and <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S1</xref>) revealed that strain HVKP4 exhibited extensive drug resistance to the tested antibiotics, demonstrating susceptibility only to tigecycline (MIC&#x202F;=&#x202F;0. 5&#x202F;mg/L) and polymyxin B (MIC &#x2264; 0.5&#x202F;mg/L). It showed resistance to all tested <italic>&#x03B2;</italic>-lactam antibiotics, including meropenem, ertapenem, and ceftazidime. In contrast, the resistance profile of strain 22ZR-42 showed significantly higher susceptibility to carbapenemsand cephalosporinscompared to HVKP4. However, 22ZR-42 remained completely resistant to cefotaxime and aztreonam. The findings demonstrate that both clinical isolates of KP exhibited severe multidrug-resistant phenotypes, with markedly limited therapeutic options among existing antimicrobial agents. This phenomenon underscores the urgent need to develop novel antibacterial drugs to combat infections caused by such resistant strains.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Antimicrobial susceptibility profiles of HVKP4 and 22ZR-42.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th>Antibiotic</th>
<th align="center" valign="top">HVKP4 (MIC, mg/L)</th>
<th align="center" valign="top">22ZR - 42 (MIC, mg/L)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="bottom">IMP</td>
<td align="center" valign="bottom"><bold>16</bold></td>
<td align="center" valign="bottom"><bold>16</bold></td>
</tr>
<tr>
<td align="left" valign="bottom">MEM</td>
<td align="center" valign="bottom"><bold>128</bold></td>
<td align="center" valign="bottom"><bold>32</bold></td>
</tr>
<tr>
<td align="left" valign="bottom">ETP</td>
<td align="center" valign="bottom"><bold>&#x003E;128</bold></td>
<td align="center" valign="bottom"><bold>64</bold></td>
</tr>
<tr>
<td align="left" valign="bottom">CMZ</td>
<td align="center" valign="bottom"><bold>128</bold></td>
<td align="center" valign="bottom">8</td>
</tr>
<tr>
<td align="left" valign="bottom">CAZ</td>
<td align="center" valign="bottom"><bold>&#x003E;128</bold></td>
<td align="center" valign="bottom"><bold>32</bold></td>
</tr>
<tr>
<td align="left" valign="bottom">CTX</td>
<td align="center" valign="bottom"><bold>&#x003E;128</bold></td>
<td align="center" valign="bottom"><bold>&#x003E;128</bold></td>
</tr>
<tr>
<td align="left" valign="bottom">TZP</td>
<td align="center" valign="bottom"><bold>&#x003E;256/4</bold></td>
<td align="center" valign="bottom"><bold>&#x003E;256/4</bold></td>
</tr>
<tr>
<td align="left" valign="bottom">SCF</td>
<td align="center" valign="bottom"><bold>&#x003E;256/128</bold></td>
<td align="center" valign="bottom"><bold>128/64</bold></td>
</tr>
<tr>
<td align="left" valign="bottom">CAV</td>
<td align="center" valign="bottom">2/4</td>
<td align="center" valign="bottom">&#x2264;0. 5/4</td>
</tr>
<tr>
<td align="left" valign="bottom">FEP</td>
<td align="center" valign="bottom"><bold>&#x003E;64</bold></td>
<td align="center" valign="bottom"><bold>&#x003E;64</bold></td>
</tr>
<tr>
<td align="left" valign="bottom">PB</td>
<td align="center" valign="bottom">&#x2264;0. 5</td>
<td align="center" valign="bottom">1</td>
</tr>
<tr>
<td align="left" valign="bottom">TGC</td>
<td align="center" valign="bottom"><bold>0. 5</bold></td>
<td align="center" valign="bottom">&#x2264;0. 25</td>
</tr>
<tr>
<td align="left" valign="bottom">CIP</td>
<td align="center" valign="bottom"><bold>32</bold></td>
<td align="center" valign="bottom">&#x2264;1</td>
</tr>
<tr>
<td align="left" valign="bottom">AK</td>
<td align="center" valign="bottom"><bold>&#x003E;128</bold></td>
<td align="center" valign="bottom">&#x2264;4</td>
</tr>
<tr>
<td align="left" valign="bottom">ATM</td>
<td align="center" valign="bottom"><bold>&#x003E;128</bold></td>
<td align="center" valign="bottom"><bold>&#x003E;128</bold></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>IMP, imipenem; MEM, meropenem; ETP, ertapenem; CMZ, cefmetazole; CAZ, ceftazidime; CTX, cefotaxime; TZP,piperacillin/tazobactam; SCF, cefoperazone/sulbactam; CAV, ceftazidime/avibactam; FEP, cefepime; PB, polymyxin B; TGC, tigecycline; CIP, ciprofloxacin; AK, amikacin; ATM, aztreonam. &#x002A;The MIC for resistance was used bold font (mg/L).</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec4">
<label>3.2</label>
<title>Synthesis and characterization of Fe/PPy</title>
<p>We successfully synthesized Fe/PPy using a one-pot method (<xref ref-type="bibr" rid="ref40">Zhang X. et al., 2023</xref>). The dynamic light scattering (DLS) measurements show the hydrodynamic diameters of Fe<sub>3</sub>O<sub>4</sub> and Fe/PPy to be 5&#x202F;nm and 7&#x202F;nm (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). This discrepancy in particle size characterization may arise from the solvation effect between the hydrophilic functional groups on the particle surface and water molecules, leading to the formation of a hydration layer on the particle surface during DLS detection (<xref ref-type="bibr" rid="ref23">Kurzbach et al., 2013</xref>). As a result, the hydrodynamic diameter measured by DLS is slightly larger than the crystallographic size observed by TEM. The XRD characterization results show that the diffraction peaks of the synthesized Fe<sub>3</sub>O<sub>4</sub> nanoparticles are consistent with the standard card (JCPDS no. 19&#x2013;0629). In the Fe/PPy composite material, however, the characteristic peaks of Fe<sub>3</sub>O<sub>4</sub> completely disappear, and only two broad diffraction bands appear in the 10&#x2013;30&#x00B0; range, which is consistent with the amorphous structure of polypyrrole. This indicates that the hydrochloric acid etching process has completely removed the Fe<sub>3</sub>O<sub>4</sub> core (<xref ref-type="fig" rid="fig1">Figure 1B</xref>).</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Characterization of Fe<sub>3</sub>O<sub>4</sub> nanoparticles and Fe/PPy nanocomposites. <bold>(A)</bold> Particle size distribution statistics of Fe<sub>3</sub>O<sub>4</sub> and Fe/PPy. <bold>(B)</bold> X-ray diffraction (XRD) patterns of Fe<sub>3</sub>O<sub>4</sub> (JCPDS no. 19-0629) and Fe/PPy.</p>
</caption>
<graphic xlink:href="fmicb-17-1749597-g001.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Two scientific plots labeled A and B compare Fe3O4 (black) and Fe/PPy (red). Panel A is a histogram showing particle size distribution. Fe3O4 particles center at 5.6 nanometers, Fe/PPy at 11.7 nanometers. Panel B is an X-ray diffraction pattern showing intensity versus two-theta, with Fe3O4 exhibiting sharp peaks and Fe/PPy showing a broad, featureless curve. Both plots illustrate the effect of polypyrrole coating on iron oxide nanoparticles.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec5">
<label>3.3</label>
<title>Photothermal properties and reactive oxygen species generation analysis</title>
<p>The UV&#x2013;Vis&#x2013;NIR absorption spectra revealed that Fe/PPy exhibited a broad and strong absorption band centered around 1,064&#x202F;nm, providing a theoretical basis for its application in NIR light therapy (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). To systematically evaluate the photothermal conversion performance of the material, we measured the temperature changes of Fe/PPy dispersions at different concentrations (25&#x2013;100&#x202F;ppm) under 1,064&#x202F;nm NIR light irradiation (1.0&#x202F;W/cm<sup>2</sup>, 15&#x202F;min). The results showed a clear concentration-dependent heating effect, with the highest temperature reaching 58. 3&#x202F;&#x00B1;&#x202F;1. 2&#x202F;&#x00B0;C (100&#x202F;&#x03BC;g/mL), significantly higher than the PBS control group (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Infrared thermal imaging further confirmed the excellent photothermal conversion performance of Fe/PPy (<xref ref-type="fig" rid="fig2">Figure 2C</xref> and <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S2</xref>). To investigate its antimicrobial mechanism, we assessed the generation of hydroxyl radicals (OH) using a methylene blue (MB) decolorization assay. In a Fenton reaction system, Fe/PPy effectively catalyzed the decomposition of H&#x2082;O&#x2082; under NIR light, generating &#x00B7;OH and leading to a significant reduction in the characteristic MB absorption peak (664&#x202F;nm). In contrast, the MB degradation rate in the NIR&#x202F;+&#x202F;H&#x2082;O&#x2082; and Fe/PPy&#x202F;+&#x202F;H&#x2082;O&#x2082; groups was considerably lower than that in the Fe/PPy&#x202F;+&#x202F;NIR&#x202F;+&#x202F;H&#x2082;O&#x2082; group (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). These findings confirm that Fe/PPy&#x202F;+&#x202F;NIR can efficiently generate reactive oxygen species through photothermal-enhanced Fenton reactions, demonstrating its potential to induce bacterial ferroptosis.</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Photothermal properties and reactive oxygen species generation analysis. <bold>(A)</bold> UV&#x2013;Vis absorption spectrum of Fe/PPy. <bold>(B)</bold> Temperature rise curves of Fe/PPy at different concentrations under 1,064&#x202F;nm laser irradiation. <bold>(C)</bold> Photothermal infrared thermal images of samples at corresponding concentrations. <bold>(D)</bold> Changes in absorbance of MBsolution under different treatment conditions.</p>
</caption>
<graphic xlink:href="fmicb-17-1749597-g002.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Panel A displays a line graph comparing absorbance versus wavelength for five concentrations, showing higher absorbance at 100 ppm and a decreasing trend as concentration lowers. Panel B presents a line graph measuring temperature against time for different concentrations, with 100 ppm reaching the highest temperature and water the lowest. Panel C shows colorimetric heat maps for each concentration, where circles transition from dark blue to orange as concentration increases, indicating temperature change. Panel D is a line graph of absorbance versus wavelength for four conditions, where the MB plus NIR group shows the highest peak near 660 nanometers and MB plus Fe/ppy plus H&#x2082;O&#x2082; plus NIR shows the lowest response.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec6">
<label>3.4</label>
<title>Antimicrobial activity of Fe/PPy</title>
<p>The combined treatment of Fe/PPy nanomaterials and NIR light significantly inhibited the growth of KP (HvKP4 and 22-ZR) in colony counting assays (with 100% killing efficiency against bothHvKP4 and 22-ZR). In contrast, no significant difference was observed between the NIR group (19.2 and 12% killing efficiency against HvKP4 and 22-ZR, respectively), the Fe/PPy group (22.1% and 17.9%, respectively), and the control group, confirming the importance of the synergistic treatment. Notably, this potent combined effect was significantly reduced (to 37.8% and 29.9%, respectively) upon addition of the ferroptosis inhibitor DFO (<xref ref-type="fig" rid="fig3">Figure 3A</xref> and <xref ref-type="supplementary-material" rid="SM1">Supplementary Table S1</xref>). The bacterial growth counting results further confirmed the antibacterial effect of the Fe/PPy nanomaterials (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S3</xref>). To visualize the antimicrobial effects of different treatments, a dual staining method using SYTO 9 Green Fluorescent Nucleic Acid Stain (SYTO 9, green fluorescence for live bacteria) and propidium iodide (PI, red fluorescence for membrane-damaged dead bacteria) was applied (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). The treated KP strains were then analyzed <italic>in situ</italic> using confocal laser scanning microscopy (CLSM). Three-dimensional CLSM imaging revealed that in the Control, NIR, and Fe/PPy groups, the bacterial colonies predominantly emitted green fluorescence, indicating that single interventions showed no significant antimicrobial activity. In contrast, the Fe/PPy&#x202F;+&#x202F;NIR group exhibited extensive red fluorescence, confirming that the synergistic treatment effectively inhibited bacterial growth. After the addition of the ferroptosis inhibitor DFO, the red fluorescence intensity in the combined treatment group decreased, and the green/red fluorescence area ratio increased, suggesting that the ferroptosis pathway was specifically blocked. Furthermore, quantitative analysis of fluorescence intensity objectively demonstrated the antibacterial efficacy of Fe/PPy nanomaterials (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S4</xref>). These dynamic fluorescence imaging results were in high agreement with the quantitative colony count data, collectively demonstrate the superior antibacterial efficacy of the synergistic treatment.</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>Analysis of the antimicrobial performance of Fe/PPy nanocomposites. <bold>(A)</bold> Plate coating experiment results for HvKP4 and 22ZR-42 under different treatment groups (from left to right: control group, NIR group, Fe/PPy group, Fe/PPy&#x202F;+&#x202F;NIR group, Fe/PPy&#x202F;+&#x202F;NIR&#x202F;+&#x202F;DFO group). <bold>(B)</bold> Confocal microscopy images of bacterial live/dead staining (SYTO 9/PI dual staining: green indicates live bacteria, red indicates dead bacteria; scale bar: 40&#x202F;&#x03BC;m).</p>
</caption>
<graphic xlink:href="fmicb-17-1749597-g003.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Figure contains agar plate images and fluorescence microscopy panels arranged for HVKP4 and 22ZR-42 bacterial strains under various treatments. Agar rows display bacterial colony counts, while fluorescence panels (SYTO 9, PI, and merged) show live (green) and dead (red) cells. Treatments are control, NIR, Fe/ppy, Fe/ppy+NIR, and Fe/ppy+NIR+DFO. Fe/ppy+NIR demonstrates the most cell death and reduced colony formation. Scale bars indicate forty micrometers.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec7">
<label>3.5</label>
<title>Ferroptosis antimicrobial mechanism analysis</title>
<p>Based on the excellent antimicrobial performance exhibited by Fe/PPy nanomaterials, we conducted an in-depth investigation into their antimicrobial mechanism. Crystal violet staining experiments were performed to observe biofilm formation. The results showedthat whilethe Control group presented complete biofilm structures, the biofilms in the NIR and Fe/PPy groups showed signs of slight disruption, though a basic structure remained intact. However, the Fe/PPy&#x202F;+&#x202F;NIR group exhibited significant biofilm disruption, which could be effectively inhibited by the ferroptosis inhibitor DFO (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). To quantitatively validate these findings, we subsequently dissolved the stained biofilms and measured the OD<sub>590</sub> values, obtaining more definitive quantitative evidence (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S5</xref>). SEM further confirmed that the biofilm structure was markedly disrupted in the Fe/PPy&#x202F;+&#x202F;NIR group (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). To explore the generation of&#x2022;OH during the antimicrobial process, we used the DCFH-DA probe to detect ROSlevels inside the bacteria. Fluorescence detection results showed that there was no significant green fluorescence in the control group; both the NIR and Fe/PPy groups exhibited only faint fluorescence signals. In contrast, the Fe/PPy&#x202F;+&#x202F;NIR group exhibited strong green fluorescence signals, which were significantly weakened in the Fe/PPy&#x202F;+&#x202F;NIR&#x202F;+&#x202F;DFO group (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). The fluorescence intensity analysis further validated this phenomenon (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S6</xref>). To further determine whether the elevated oxidative stress led to lipid peroxidation, malondialdehyde (MDA) levels were quantified as an indicator of membrane lipid damage. Fe/PPy&#x202F;+&#x202F;NIR induced a significant increase in MDA content in both hvKP4 and 22ZR-42 compared with the Control, NIR, and Fe/PPy groups (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S7</xref>). Notably, the addition of the ferroptosis inhibitor deferoxamine (DFO) markedly attenuated MDA accumulation, indicating that the lipid peroxidation process was iron-dependent. These experimental results demonstrate that Fe/PPy combined with NIR irradiation exerts significant antimicrobial effects by inducing bacterial ferroptosis, as evidenced by elevated reactive oxygen species generation and lipid peroxidation.</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>Antimicrobial mechanism analysis of HvKP4 and 22ZR-42 treated with Fe/PPy. <bold>(A)</bold> Quantitative analysis of biofilm formation using crystal violet staining in different treatment groups (from left to right: control group, NIR group, Fe/PPy group, Fe/PPy&#x202F;+&#x202F;NIR group, Fe/PPy&#x202F;+&#x202F;NIR&#x202F;+&#x202F;DFO group). <bold>(B)</bold> SEM observation of the three-dimensional biofilm structure under different treatments (scale bar: 1&#x202F;&#x03BC;m). <bold>(C)</bold> Intracellular ROS levels detected by DCFH-DA staining (green fluorescence intensity positively correlates with ROS content; scale bar: 40&#x202F;&#x03BC;m).</p>
</caption>
<graphic xlink:href="fmicb-17-1749597-g004.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Scientific figure comparing biofilm reduction of HVKP4 and 22ZR-42 strains under different treatments. Panel A shows stained biofilm discs, Panel B presents SEM images of bacterial clusters, and Panel C displays bright field and fluorescence micrographs, with merged views, under control, NIR, Fe/ppy, Fe/ppy+NIR, and Fe/ppy+NIR+DFO conditions.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec8">
<label>3.6</label>
<title>Biocompatibility of Fe/PPy</title>
<p>The biocompatibility of nanomaterials is crucial for assessing their safety in biomedical applications. In this study, the safety of Fe/PPy nanomaterials was comprehensively evaluated through hemolysis and <italic>in vivo</italic> toxicity experiments (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). The hemolysis assay showed that the hemolysis rate was below the international standard (&#x003C;5%), indicating that the material does not cause erythrocyte membrane damage (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). <italic>In vivo</italic> experiments were conducted, where animals were orally gavaged with the material, and body weight changes were monitored for 7&#x202F;days (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). The results showed no significant differences between the experimental and control groups (<italic>p</italic>&#x202F;&#x003E;&#x202F;0. 05), suggesting that the material did not induce systemic toxicity. To systematically assess the potential impact of the material on the body, blood routine and biochemical analyses were conducted at the appropriate time points post-administration. Blood routine analysis showed that red blood cell (RBC) count, white blood cell (WBC) differential count, and platelet (PLT) parameters were all within normal physiological ranges. Additionally, key liver and kidney function indicators, including Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), Albumin (ALB), Blood Urea Nitrogen (BUN), and Creatinine (CRE), were measured. Showed no significant differences between the experimental and control groups (<italic>p</italic>&#x202F;&#x003E;&#x202F;0. 05), indicating that the material did not cause any abnormalities in liver and kidney metabolic functions (<xref ref-type="fig" rid="fig5">Figures 5D</xref>&#x2013;<xref ref-type="fig" rid="fig5">G</xref>) At the study endpoint, animals were sacrificed, and anatomical observations along with tissue pathological analyses were performed on the major organs (heart, liver, spleen, lungs, kidneys, small intestine). Histological analysis via H&#x0026;E staining revealed that the organ structures in the experimental groups were intact, with no inflammatory cell infiltration, congestion, edema, or necrosis observed. Notably, liver and kidney tissues, which are closely related to nanoparticle metabolism, maintained normal morphological characteristics, including intact hepatic lobule structures and glomerular filtration barriers. The results from this series of experiments confirm that Fe/PPy demonstrates excellent biocompatibility and safety under the experimental conditions (<xref ref-type="fig" rid="fig5">Figure 5F</xref>).</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>Biological safety evaluation of Fe/PPy nanomaterials. <bold>(A,B)</bold> Hemolysis assay results showing blood sample morphology and quantitative hemolysis rates after treatment with various concentrations of Fe/PPy. <bold>(C)</bold> Body weight change curves of two female mouse groups. <bold>(D,E)</bold> Liver and kidney function indices and blood routine test results 1&#x202F;day after administration. <bold>(F,G)</bold> Liver and kidney function indices and blood routine test results 7&#x202F;days after administration. <bold>(H)</bold> Histopathological analysis of major organs via H&#x0026;E staining at both one-day and seven-day time points (scale bar: 100&#x202F;&#x03BC;m) (&#x002A;&#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.001, &#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.01, &#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05).</p>
</caption>
<graphic xlink:href="fmicb-17-1749597-g005.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Panel A shows six centrifuge tubes with color variations indicating samples exposed to different Fe/PPy concentrations. Panel B presents a bar chart of hemolysis percentages across samples, showing a significant decrease with higher Fe/PPy concentrations. Panel C displays a line graph of body weight over seven days for control and Fe/PPy groups. Panels D and F show bar graphs comparing biochemical indices between control and Fe/PPy groups, while Panels E and G compare routine blood indices under different treatments. Panel H provides histological images of heart, liver, spleen, lung, and kidney tissues at one and seven days post-treatment, comparing control and Fe/PPy groups, with a 100 micrometer scale bar.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec9">
<label>3.7</label>
<title><italic>In vivo</italic> de-colonization of Fe/PPy</title>
<p>Based on the photothermal antimicrobial properties of Fe/PPy and the previously verified biological safety (<xref ref-type="fig" rid="fig4">Figures 4</xref>, <xref ref-type="fig" rid="fig5">5</xref>), this study established an intestinal colonization model of KP in C57BL/6 female mice to evaluate the decolonization effect. The model was first established via oral gavage (1&#x202F;&#x00D7;&#x202F;10<sup>8</sup> Colony-forming units, CFU) to induce infections with 22-ZR and HvKP4 strains, followed by treatment (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). 24&#x202F;h post-inoculation, female mice in the Fe/PPy and Fe/PPy&#x202F;+&#x202F;NIR groups were gavaged with an Fe/PPy suspension (20&#x202F;mg/kg), while the Control and NIR groups were also included (<italic>n</italic>&#x202F;=&#x202F;5 per group). 4&#x202F;h later, female mice were anesthetized by intraperitoneal administration of tribromoethanol (250&#x202F;mg/kg), and were immediately subjected to 1,064&#x202F;nm NIR irradiation (1.0&#x202F;W/cm<sup>2</sup>, 8&#x202F;min) to activate the photothermal effect. This wavelength, compared to 808&#x202F;nm, provides superior tissue penetration, ensuring effective heating in the intestinal tract. Fecal samples were collected 24&#x202F;h after treatment, and 16S rRNA high-throughput sequencing was used to analyze the gut microbiota composition. CIRCOS plot analysis revealed that the Fe/PPy&#x202F;+&#x202F;NIR group showed a complete eradication of KP (22-ZR: 0%; HvKP4: 0%), compared to the Control group (22-ZR: 38%; HvKP4: 39%). The NIR group (22-ZR: 31%; HvKP4: 34%) and the Fe/PPy group (22-ZR: 30%; HvKP4: 27%) maintained significant colonization, confirming the necessity of the photothermal synergistic effect (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). Additionally, Klebsiella colonization in the intestines of 22-ZR-infected female mice in the Control group was slightly lower than that of HvKP4 (14% vs. 8%), with the HVKP4 strain exhibiting a stronger intestinal residence ability (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S8</xref>). At the experimental endpoint, histological examination of H&#x0026;E-stained tissues from all treatment groups demonstrated well-preserved tissue morphology in the dissected mice (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S9</xref>).</p>
<fig position="float" id="fig6">
<label>Figure 6</label>
<caption>
<p><italic>In vivo</italic> KP decolonization analysis. <bold>(A)</bold> Timeline depicting the establishment of a murine infection model and subsequent treatment with nanomaterials. <bold>(B)</bold> Circos analysis of gut microbiota under various treatment conditions in the 22ZR-42 infection group; <bold>(C)</bold> Circos analysis of gut microbiota under various treatment conditions in the HvKP4 infection group.</p>
</caption>
<graphic xlink:href="fmicb-17-1749597-g006.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Illustration showing an experimental timeline where mice undergo bacterial inoculation, nanomaterial gavage, NIR irradiation, and subsequent gut microbiota analysis, with labeled days for each step. Below, two circular chord diagrams labeled HvKP4 and 22ZR-42 compare gut microbiota composition across four groups, displaying color-coded links among bacterial genera and treatment groups, with percentages for FePPy+NIR, NIR, control, and cyh conditions.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec sec-type="conclusions" id="sec10">
<label>4</label>
<title>Conclusion</title>
<p>We successfully synthesized ultrasmall Fe/PPy nanopolymers with NIR-responsive properties using a hard-template method. Under 1,064&#x202F;nm NIR irradiation, this material efficiently eliminates <italic>Klebsiella pneumoniae</italic> via a synergistic photothermal&#x2013;ferroptosis mechanism, achieving significant <italic>in vivo</italic> intestinal decolonization. Mechanistic investigations indicate that the NIR-induced photothermal effect not only contributes to bacterial ablation but, more importantly, promotes iron-dependent lipid peroxidation, thereby triggering bacterial ferroptosis. This dual-action mechanism underlies the high antibacterial efficacy of the Fe/PPy nanoplatform. Benefiting from the superior tissue penetration depth of 1,064&#x202F;nm NIR light, this strategy shows distinct advantages for the treatment of deep-seated infections caused by multidrug-resistant <italic>K. pneumoniae</italic>. Notably, although Fe/PPy demonstrated enhanced antibacterial efficacy against HvKP4 and 22ZR-42 in the murine intestinal infection model, the molecular basis underlying this preferential susceptibility remains to be fully elucidated. Previous studies have suggested that the unique capsular polysaccharide structures and surface physicochemical properties of <italic>K. pneumoniae</italic> may facilitate nanoparticle adsorption and iron-dependent killing. However, systematic validation of these hypotheses under physiologically relevant polymicrobial conditions is still required. Future studies employing complex gut microbiota models and human-derived samples will be essential to comprehensively clarify the selectivity and translational potential of this nanotherapeutic strategy.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec13">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">Supplementary material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec sec-type="ethics-statement" id="sec14">
<title>Ethics statement</title>
<p>The animal study was approved by the Human Research Ethics Committee of Second Affiliated Hospital, Zhejiang University School of Medicine. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec sec-type="author-contributions" id="sec15">
<title>Author contributions</title>
<p>XZ: Data curation, Writing &#x2013; original draft. ZY: Software, Writing &#x2013; review &#x0026; editing. BZ: Writing &#x2013; review &#x0026; editing. SS: Writing &#x2013; review &#x0026; editing. YW: Writing &#x2013; review &#x0026; editing. YZ: Writing &#x2013; review &#x0026; editing. DG: Writing &#x2013; review &#x0026; editing. HT: Writing &#x2013; review &#x0026; editing. RZ: Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec sec-type="COI-statement" id="sec16">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="sec17">
<title>Generative AI statement</title>
<p>The author(s) declared that Generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="sec18">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="sec19">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2026.1749597/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fmicb.2026.1749597/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.PDF" id="SM1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bankar</surname><given-names>S. B.</given-names></name> <name><surname>Bule</surname><given-names>M. V.</given-names></name> <name><surname>Singhal</surname><given-names>R. S.</given-names></name> <name><surname>Ananthanarayan</surname><given-names>L.</given-names></name></person-group> (<year>2009</year>). <article-title>Glucose oxidase &#x2014; an overview</article-title>. <source>Biotechnol. Adv.</source> <volume>27</volume>, <fpage>489</fpage>&#x2013;<lpage>501</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biotechadv.2009.04.003</pub-id>, <pub-id pub-id-type="pmid">19374943</pub-id></mixed-citation></ref>
<ref id="ref2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bengoechea</surname><given-names>J. A.</given-names></name> <name><surname>Sa Pessoa</surname><given-names>J.</given-names></name></person-group> (<year>2019</year>). <article-title><italic>Klebsiella pneumoniae</italic> infection biology: living to counteract host defences</article-title>. <source>FEMS Microbiol. Rev.</source> <volume>43</volume>, <fpage>123</fpage>&#x2013;<lpage>144</lpage>. doi: <pub-id pub-id-type="doi">10.1093/femsre/fuy043</pub-id></mixed-citation></ref>
<ref id="ref3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blair</surname><given-names>J. M. A.</given-names></name> <name><surname>Webber</surname><given-names>M. A.</given-names></name> <name><surname>Baylay</surname><given-names>A. J.</given-names></name> <name><surname>Ogbolu</surname><given-names>D. O.</given-names></name> <name><surname>Piddock</surname><given-names>L. J. V.</given-names></name></person-group> (<year>2015</year>). <article-title>Molecular mechanisms of antibiotic resistance</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>13</volume>, <fpage>42</fpage>&#x2013;<lpage>51</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrmicro3380</pub-id>, <pub-id pub-id-type="pmid">25435309</pub-id></mixed-citation></ref>
<ref id="ref4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>R. Y. K.</given-names></name> <name><surname>Nang</surname><given-names>S. C.</given-names></name> <name><surname>Chan</surname><given-names>H. -K.</given-names></name> <name><surname>Li</surname><given-names>J.</given-names></name></person-group> (<year>2022</year>). <article-title>Novel antimicrobial agents for combating antibiotic-resistant bacteria</article-title>. <source>Adv. Drug Deliv. Rev.</source> <volume>187</volume>:<fpage>114378</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.addr.2022.114378</pub-id></mixed-citation></ref>
<ref id="ref5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X.</given-names></name> <name><surname>Yu</surname><given-names>C.</given-names></name> <name><surname>Kang</surname><given-names>R.</given-names></name> <name><surname>Kroemer</surname><given-names>G.</given-names></name> <name><surname>Tang</surname><given-names>D.</given-names></name></person-group> (<year>2021</year>). <article-title>Cellular degradation systems in ferroptosis</article-title>. <source>Cell Death Differ.</source> <volume>28</volume>, <fpage>1135</fpage>&#x2013;<lpage>1148</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41418-020-00728-1</pub-id>, <pub-id pub-id-type="pmid">33462411</pub-id></mixed-citation></ref>
<ref id="ref6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choby</surname><given-names>J. E.</given-names></name> <name><surname>Howard-Anderson</surname><given-names>J.</given-names></name> <name><surname>Weiss</surname><given-names>D. S.</given-names></name></person-group> (<year>2020</year>). <article-title>Hypervirulent <italic>Klebsiella pneumoniae</italic> &#x2013; clinical and molecular perspectives</article-title>. <source>J. Intern. Med.</source> <volume>287</volume>, <fpage>283</fpage>&#x2013;<lpage>300</lpage>. doi: <pub-id pub-id-type="doi">10.1111/joim.13007</pub-id>, <pub-id pub-id-type="pmid">31677303</pub-id></mixed-citation></ref>
<ref id="ref7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>X.</given-names></name> <name><surname>Ruan</surname><given-names>Q.</given-names></name> <name><surname>Zhuo</surname><given-names>X.</given-names></name> <name><surname>Xia</surname><given-names>X.</given-names></name> <name><surname>Hu</surname><given-names>J.</given-names></name> <name><surname>Fu</surname><given-names>R.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Photothermal nanomaterials: a powerful light-to-heat converter</article-title>. <source>Chem. Rev.</source> <volume>123</volume>, <fpage>6891</fpage>&#x2013;<lpage>6952</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acs.chemrev.3c00159</pub-id>, <pub-id pub-id-type="pmid">37133878</pub-id></mixed-citation></ref>
<ref id="ref8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixon</surname><given-names>S. J.</given-names></name> <name><surname>Lemberg</surname><given-names>K. M.</given-names></name> <name><surname>Lamprecht</surname><given-names>M. R.</given-names></name> <name><surname>Skouta</surname><given-names>R.</given-names></name> <name><surname>Zaitsev</surname><given-names>E. M.</given-names></name> <name><surname>Gleason</surname><given-names>C. E.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Ferroptosis: an Iron-dependent form of nonapoptotic cell death</article-title>. <source>Cell</source> <volume>149</volume>, <fpage>1060</fpage>&#x2013;<lpage>1072</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2012.03.042</pub-id>, <pub-id pub-id-type="pmid">22632970</pub-id></mixed-citation></ref>
<ref id="ref9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eller</surname><given-names>K. A.</given-names></name> <name><surname>Aunins</surname><given-names>T. R.</given-names></name> <name><surname>Courtney</surname><given-names>C. M.</given-names></name> <name><surname>Campos</surname><given-names>J. K.</given-names></name> <name><surname>Otoupal</surname><given-names>P. B.</given-names></name> <name><surname>Erickson</surname><given-names>K. E.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Facile accelerated specific therapeutic (FAST) platform develops antisense therapies to counter multidrug-resistant bacteria</article-title>. <source>Commun. Biol.</source> <volume>4</volume>:<fpage>331</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s42003-021-01856-1</pub-id></mixed-citation></ref>
<ref id="ref10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>Q.</given-names></name> <name><surname>Feng</surname><given-names>Y.</given-names></name> <name><surname>McNally</surname><given-names>A.</given-names></name> <name><surname>Zong</surname><given-names>Z.</given-names></name></person-group> (<year>2022</year>). <article-title>Characterization of phage resistance and phages capable of intestinal decolonization of carbapenem-resistant <italic>Klebsiella pneumoniae</italic> in mice</article-title>. <source>Commun. Biol.</source> <volume>5</volume>:<fpage>48</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s42003-022-03001-y</pub-id></mixed-citation></ref>
<ref id="ref11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fromain</surname><given-names>A.</given-names></name></person-group> (<year>2023</year>). <article-title>Photothermia at the nanoscale induces ferroptosis via nanoparticle degradation</article-title>. <source>Nat. Commun.</source> <volume>14</volume>:<fpage>4637</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-023-40258-1</pub-id></mixed-citation></ref>
<ref id="ref12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fulaz</surname><given-names>S.</given-names></name> <name><surname>Vitale</surname><given-names>S.</given-names></name> <name><surname>Quinn</surname><given-names>L.</given-names></name> <name><surname>Casey</surname><given-names>E.</given-names></name></person-group> (<year>2019</year>). <article-title>Nanoparticle-biofilm interactions: the role of the EPS matrix</article-title>. <source>Trends Microbiol.</source> <volume>27</volume>, <fpage>915</fpage>&#x2013;<lpage>926</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tim.2019.07.004</pub-id>, <pub-id pub-id-type="pmid">31420126</pub-id></mixed-citation></ref>
<ref id="ref13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gan</surname><given-names>Y.</given-names></name> <name><surname>Deng</surname><given-names>J.</given-names></name> <name><surname>Hao</surname><given-names>Q.</given-names></name> <name><surname>Huang</surname><given-names>Y.</given-names></name> <name><surname>Han</surname><given-names>T.</given-names></name> <name><surname>Xu</surname><given-names>J.&#x2011;G.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>UTP11 deficiency suppresses cancer development via nucleolar stress and ferroptosis</article-title>. <source>Redox Biol.</source> <volume>62</volume>:<fpage>102705</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.redox.2023.102705</pub-id></mixed-citation></ref>
<ref id="ref14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>D.</given-names></name> <name><surname>Dong</surname><given-names>N.</given-names></name> <name><surname>Zheng</surname><given-names>Z.</given-names></name> <name><surname>Lin</surname><given-names>D.</given-names></name> <name><surname>Huang</surname><given-names>M.</given-names></name> <name><surname>Wang</surname><given-names>L.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>A fatal outbreak of ST11 carbapenem-resistant hypervirulent <italic>Klebsiella pneumoniae</italic> in a Chinese hospital: a molecular epidemiological study</article-title>. <source>Lancet Infect. Dis.</source> <volume>18</volume>, <fpage>37</fpage>&#x2013;<lpage>46</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1473-3099(17)30489-9</pub-id>, <pub-id pub-id-type="pmid">28864030</pub-id></mixed-citation></ref>
<ref id="ref15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerrieri</surname><given-names>D.</given-names></name> <name><surname>Ambrosi</surname><given-names>N. G.</given-names></name> <name><surname>Romeo</surname><given-names>H.</given-names></name> <name><surname>Salaberry</surname><given-names>J.</given-names></name> <name><surname>Toniolo</surname><given-names>M. F.</given-names></name> <name><surname>Remolins</surname><given-names>C.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Secretory leukocyte proteinase inhibitor protects acute kidney injury through immune and non-immune pathways</article-title>. <source>Shock</source> <volume>56</volume>, <fpage>1019</fpage>&#x2013;<lpage>1027</lpage>. doi: <pub-id pub-id-type="doi">10.1097/SHK.0000000000001785</pub-id>, <pub-id pub-id-type="pmid">33882512</pub-id></mixed-citation></ref>
<ref id="ref16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>F.</given-names></name> <name><surname>Pan</surname><given-names>Y.</given-names></name> <name><surname>Li</surname><given-names>H.</given-names></name> <name><surname>Han</surname><given-names>R.</given-names></name> <name><surname>Liu</surname><given-names>X.</given-names></name> <name><surname>Ma</surname><given-names>R.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Carbapenem-resistant <italic>Klebsiella pneumoniae</italic> capsular types, antibiotic resistance and virulence factors in China: a longitudinal, multi-Centre study</article-title>. <source>Nat. Microbiol.</source> <volume>9</volume>, <fpage>814</fpage>&#x2013;<lpage>829</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41564-024-01612-1</pub-id>, <pub-id pub-id-type="pmid">38424289</pub-id></mixed-citation></ref>
<ref id="ref17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huo</surname><given-names>S.</given-names></name> <name><surname>Lyu</surname><given-names>Z.</given-names></name> <name><surname>Wang</surname><given-names>X.</given-names></name> <name><surname>Liu</surname><given-names>S.</given-names></name> <name><surname>Chen</surname><given-names>X.</given-names></name> <name><surname>Yang</surname><given-names>M.</given-names></name> <etal/></person-group>. (<year>2025</year>). <article-title>Engineering mesoporous polydopamine-based potentiate STING pathway activation for advanced anti-biofilm therapy</article-title>. <source>Biomaterials</source> <volume>312</volume>:<fpage>122739</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biomaterials.2024.122739</pub-id></mixed-citation></ref>
<ref id="ref18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imlay</surname><given-names>J. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Cellular Defenses against superoxide and hydrogen peroxide</article-title>. <source>Annu. Rev. Biochem.</source> <volume>77</volume>, <fpage>755</fpage>&#x2013;<lpage>776</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev.biochem.77.061606.161055</pub-id>, <pub-id pub-id-type="pmid">18173371</pub-id></mixed-citation></ref>
<ref id="ref19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imlay</surname><given-names>J. A.</given-names></name></person-group> (<year>2013</year>). <article-title>The molecular mechanisms and physiological consequences of oxidative stress: lessons from a model bacterium</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>11</volume>, <fpage>443</fpage>&#x2013;<lpage>454</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrmicro3032</pub-id>, <pub-id pub-id-type="pmid">23712352</pub-id></mixed-citation></ref>
<ref id="ref20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>X.</given-names></name> <name><surname>Zhu</surname><given-names>Y.</given-names></name> <name><surname>Jia</surname><given-names>P.</given-names></name> <name><surname>Li</surname><given-names>C.</given-names></name> <name><surname>Chu</surname><given-names>X.</given-names></name> <name><surname>Sun</surname><given-names>T.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>The key role of iroBCDN-lacking pLVPK-like plasmid in the evolution of the most prevalent hypervirulent carbapenem-resistant ST11-KL64 <italic>Klebsiella pneumoniae</italic> in China</article-title>. <source>Drug Resist. Updat.</source> <volume>77</volume>:<fpage>101137</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.drup.2024.101137</pub-id></mixed-citation></ref>
<ref id="ref21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>X.</given-names></name> <name><surname>Stockwell</surname><given-names>B. R.</given-names></name> <name><surname>Conrad</surname><given-names>M.</given-names></name></person-group> (<year>2021</year>). <article-title>Ferroptosis: mechanisms, biology and role in disease</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>22</volume>, <fpage>266</fpage>&#x2013;<lpage>282</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41580-020-00324-8</pub-id>, <pub-id pub-id-type="pmid">33495651</pub-id></mixed-citation></ref>
<ref id="ref22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D.</given-names></name> <name><surname>Kwon</surname><given-names>S. J.</given-names></name> <name><surname>Wu</surname><given-names>X.</given-names></name> <name><surname>Sauve</surname><given-names>J.</given-names></name> <name><surname>Lee</surname><given-names>I.</given-names></name> <name><surname>Nam</surname><given-names>J.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Selective killing of pathogenic Bacteria by antimicrobial silver nanoparticle&#x2014;Cell Wall binding domain conjugates</article-title>. <source>ACS Appl. Mater. Interfaces</source> <volume>10</volume>, <fpage>13317</fpage>&#x2013;<lpage>13324</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acsami.8b00181</pub-id>, <pub-id pub-id-type="pmid">29619821</pub-id></mixed-citation></ref>
<ref id="ref23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurzbach</surname><given-names>D.</given-names></name> <name><surname>Hassouneh</surname><given-names>W.</given-names></name> <name><surname>McDaniel</surname><given-names>J.</given-names></name> <name><surname>Jaumann</surname><given-names>E. A.</given-names></name> <name><surname>Chilkoti</surname><given-names>A.</given-names></name> <name><surname>Hinderberger</surname><given-names>D.</given-names></name></person-group> (<year>2013</year>). <article-title>Hydration layer coupling and cooperativity in phase behavior of stimulus responsive peptide polymers</article-title>. <source>J. Am. Chem. Soc.</source> <volume>135</volume>, <fpage>11299</fpage>&#x2013;<lpage>11308</lpage>. doi: <pub-id pub-id-type="doi">10.1021/ja4047872</pub-id>, <pub-id pub-id-type="pmid">23822733</pub-id></mixed-citation></ref>
<ref id="ref24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name> <name><surname>Hu</surname><given-names>D.</given-names></name> <name><surname>Ma</surname><given-names>X.</given-names></name> <name><surname>Li</surname><given-names>D.</given-names></name> <name><surname>Tian</surname><given-names>D.</given-names></name> <name><surname>Gong</surname><given-names>Y.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Convergence of carbapenem resistance and hypervirulence leads to high mortality in patients with postoperative <italic>Klebsiella pneumoniae</italic> meningitis</article-title>. <source>J. Glob. Antimicrob. Resist.</source> <volume>27</volume>, <fpage>95</fpage>&#x2013;<lpage>100</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jgar.2021.02.035</pub-id>, <pub-id pub-id-type="pmid">34133987</pub-id></mixed-citation></ref>
<ref id="ref25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C.</given-names></name> <name><surname>Dong</surname><given-names>N.</given-names></name> <name><surname>Zeng</surname><given-names>Y.</given-names></name> <name><surname>Lu</surname><given-names>J.</given-names></name> <name><surname>Chen</surname><given-names>J.</given-names></name> <name><surname>Wang</surname><given-names>Y.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Co-transfer of last-line antibiotic resistance and virulence operons by an IncFIBk-FII-X3-ColKP3 hybrid plasmid in <italic>Klebsiella pneumoniae</italic></article-title>. <source>J. Antimicrob. Chemother.</source> <volume>77</volume>, <fpage>1856</fpage>&#x2013;<lpage>1861</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dkac121</pub-id>, <pub-id pub-id-type="pmid">35445265</pub-id></mixed-citation></ref>
<ref id="ref26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.</given-names></name> <name><surname>Smith</surname><given-names>S.</given-names></name> <name><surname>Wang</surname><given-names>C.</given-names></name></person-group> (<year>2023</year>). <article-title>Photothermal attenuation of Cancer cell stemness, chemoresistance, and migration using CD44-targeted MoS<sub>2</sub> nanosheets</article-title>. <source>Nano Lett.</source> <volume>23</volume>, <fpage>1989</fpage>&#x2013;<lpage>1999</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acs.nanolett.3c00089</pub-id>, <pub-id pub-id-type="pmid">36827209</pub-id></mixed-citation></ref>
<ref id="ref27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makvandi</surname><given-names>P.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Bioengineered materials with selective antimicrobial toxicity in biomedicine</article-title>. <source>Mil. Med. Res.</source> <volume>10</volume>:<fpage>8</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.drup.2024.101083</pub-id></mixed-citation></ref>
<ref id="ref28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>W. R.</given-names></name> <name><surname>Arias</surname><given-names>C. A.</given-names></name></person-group> (<year>2024</year>). <article-title>ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>22</volume>, <fpage>598</fpage>&#x2013;<lpage>616</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41579-024-01054-w</pub-id>, <pub-id pub-id-type="pmid">38831030</pub-id></mixed-citation></ref>
<ref id="ref29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osbelt</surname><given-names>L.</given-names></name> <name><surname>Wende</surname><given-names>M.</given-names></name> <name><surname>Alm&#x00E1;si</surname><given-names>&#x00C9;.</given-names></name> <name><surname>Derksen</surname><given-names>E.</given-names></name> <name><surname>Muthukumarasamy</surname><given-names>U.</given-names></name> <name><surname>Lesker</surname><given-names>T. R.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title><italic>Klebsiella oxytoca</italic> causes colonization resistance against multidrug-resistant <italic>K. pneumoniae</italic> in the gut via cooperative carbohydrate competition</article-title>. <source>Cell Host Microbe</source> <volume>29</volume>, <fpage>1663</fpage>&#x2013;<lpage>1679</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.chom.2021.09.003</pub-id></mixed-citation></ref>
<ref id="ref30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pu</surname><given-names>D.</given-names></name> <name><surname>Zhao</surname><given-names>J.</given-names></name> <name><surname>Chang</surname><given-names>K.</given-names></name> <name><surname>Zhuo</surname><given-names>X.</given-names></name> <name><surname>Cao</surname><given-names>B.</given-names></name></person-group> (<year>2023</year>). <article-title>&#x201C;Superbugs&#x201D; with hypervirulence and carbapenem resistance in <italic>Klebsiella pneumoniae</italic>: the rise of such emerging nosocomial pathogens in China</article-title>. <source>Sci. Bull.</source> <volume>68</volume>, <fpage>2658</fpage>&#x2013;<lpage>2670</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.scib.2023.09.040</pub-id></mixed-citation></ref>
<ref id="ref31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>T. A.</given-names></name> <name><surname>Marr</surname><given-names>C. M.</given-names></name></person-group> (<year>2019</year>). <article-title>Hypervirulent <italic>Klebsiella pneumoniae</italic></article-title>. <source>Clin. Microbiol. Rev.</source> <volume>32</volume>, <fpage>10</fpage>&#x2013;<lpage>1128</lpage>. doi: <pub-id pub-id-type="doi">10.1128/CMR.00001-19</pub-id></mixed-citation></ref>
<ref id="ref32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siu</surname><given-names>L. K.</given-names></name> <name><surname>Yeh</surname><given-names>K. -M.</given-names></name> <name><surname>Lin</surname><given-names>J. -C.</given-names></name> <name><surname>Fung</surname><given-names>C. -P.</given-names></name> <name><surname>Chang</surname><given-names>F. -Y.</given-names></name></person-group> (<year>2012</year>). <article-title><italic>Klebsiella pneumoniae</italic> liver abscess: a new invasive syndrome</article-title>. <source>Lancet Infect. Dis.</source> <volume>12</volume>, <fpage>881</fpage>&#x2013;<lpage>887</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1473-3099(12)70205-0</pub-id>, <pub-id pub-id-type="pmid">23099082</pub-id></mixed-citation></ref>
<ref id="ref33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q.</given-names></name> <name><surname>Wang</surname><given-names>R.</given-names></name> <name><surname>Wang</surname><given-names>S.</given-names></name> <name><surname>Zhang</surname><given-names>A.</given-names></name> <name><surname>Duan</surname><given-names>Q.</given-names></name> <name><surname>Sun</surname><given-names>S.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Expansion and transmission dynamics of high risk carbapenem-resistant <italic>Klebsiella pneumoniae</italic> subclones in China: an epidemiological, spatial, genomic analysis</article-title>. <source>Drug Resist. Updat.</source> <volume>74</volume>:<fpage>101083</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.drup.2024.101083</pub-id></mixed-citation></ref>
<ref id="ref34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>R.</given-names></name> <name><surname>Zhang</surname><given-names>A.</given-names></name> <name><surname>Sun</surname><given-names>S.</given-names></name> <name><surname>Yin</surname><given-names>G.</given-names></name> <name><surname>Wu</surname><given-names>X.</given-names></name> <name><surname>Ding</surname><given-names>Q.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Increase in antioxidant capacity associated with the successful subclone of hypervirulent carbapenem-resistant <italic>Klebsiella pneumoniae</italic> ST11-KL64</article-title>. <source>Nat. Commun.</source> <volume>15</volume>:<fpage>67</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.drup.2024.101083</pub-id></mixed-citation></ref>
<ref id="ref35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>J.</given-names></name> <name><surname>Wang</surname><given-names>H.</given-names></name> <name><surname>Ma</surname><given-names>R.</given-names></name> <name><surname>Fan</surname><given-names>J.</given-names></name> <name><surname>Quan</surname><given-names>Q.</given-names></name> <name><surname>Zhang</surname><given-names>Z.</given-names></name> <etal/></person-group>. (<year>2025</year>). <article-title>The molybdate transport protein ModA regulates nitrate reductase activity to increase the intestinal colonization and extraintestinal dissemination of <italic>Klebsiella pneumoniae</italic> in the inflamed gut</article-title>. <source>Virulence</source> <volume>16</volume>:<fpage>2474185</fpage>. doi: <pub-id pub-id-type="doi">10.1080/21505594.2025.2474185</pub-id></mixed-citation></ref>
<ref id="ref36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>Y.</given-names></name> <name><surname>Zhang</surname><given-names>L.</given-names></name> <name><surname>Liu</surname><given-names>F.</given-names></name> <name><surname>Dai</surname><given-names>F.</given-names></name> <name><surname>Kong</surname><given-names>L.</given-names></name> <name><surname>Ma</surname><given-names>D.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Alkaline &#x201C;Nanoswords&#x201D; coordinate ferroptosis-like bacterial death for antibiosis and osseointegration</article-title>. <source>ACS Nano</source> <volume>17</volume>, <fpage>2711</fpage>&#x2013;<lpage>2724</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acsnano.2c10960</pub-id></mixed-citation></ref>
<ref id="ref37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X.</given-names></name> <name><surname>Dong</surname><given-names>N.</given-names></name> <name><surname>Chan</surname><given-names>E. W. -C.</given-names></name> <name><surname>Zhang</surname><given-names>R.</given-names></name> <name><surname>Chen</surname><given-names>S.</given-names></name></person-group> (<year>2021</year>). <article-title>Carbapenem resistance-encoding and virulence-encoding conjugative plasmids in <italic>Klebsiella pneumoniae</italic></article-title>. <source>Trends Microbiol.</source> <volume>29</volume>, <fpage>65</fpage>&#x2013;<lpage>83</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tim.2020.04.012</pub-id>, <pub-id pub-id-type="pmid">32448764</pub-id></mixed-citation></ref>
<ref id="ref38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X.</given-names></name> <name><surname>Sun</surname><given-names>Q.</given-names></name> <name><surname>Li</surname><given-names>J.</given-names></name> <name><surname>Jiang</surname><given-names>Y.</given-names></name> <name><surname>Li</surname><given-names>Y.</given-names></name> <name><surname>Lin</surname><given-names>J.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Molecular epidemiology of carbapenem-resistant hypervirulent <italic>Klebsiella pneumoniae</italic> in China</article-title>. <source>Emerg. Microbes Infect.</source> <volume>11</volume>, <fpage>841</fpage>&#x2013;<lpage>849</lpage>. doi: <pub-id pub-id-type="doi">10.1080/22221751.2022.2049458</pub-id>, <pub-id pub-id-type="pmid">35236251</pub-id></mixed-citation></ref>
<ref id="ref39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q.</given-names></name> <name><surname>Su</surname><given-names>X.</given-names></name> <name><surname>Zhang</surname><given-names>C.</given-names></name> <name><surname>Chen</surname><given-names>W.</given-names></name> <name><surname>Wang</surname><given-names>Y.</given-names></name> <name><surname>Yang</surname><given-names>X.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title><italic>Klebsiella pneumoniae</italic> induces inflammatory bowel disease through Caspase-11&#x2013;mediated IL18 in the gut epithelial cells</article-title>. <source>Cell. Mol. Gastroenterol. Hepatol.</source> <volume>15</volume>, <fpage>613</fpage>&#x2013;<lpage>632</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jcmgh.2022.11.005</pub-id>, <pub-id pub-id-type="pmid">36436756</pub-id></mixed-citation></ref>
<ref id="ref40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.</given-names></name> <name><surname>Wang</surname><given-names>T.</given-names></name> <name><surname>Zhou</surname><given-names>Z.</given-names></name> <name><surname>Zhou</surname><given-names>T.</given-names></name> <name><surname>Shen</surname><given-names>Y.</given-names></name> <name><surname>Fang</surname><given-names>W.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>NIR light-activated and RGD-conjugated ultrasmall Fe/PPy Nanopolymers for enhanced tumor photothermal Ferrotherapy and MR imaging</article-title>. <source>Chem. Eur. J.</source> <volume>29</volume>:<fpage>e202302125</fpage>. doi: <pub-id pub-id-type="doi">10.1002/chem.202302125</pub-id></mixed-citation></ref>
</ref-list>
<fn-group>
<fn fn-type="custom" custom-type="edited-by" id="fn0001"><p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3096159/overview">Fangyu Ren</ext-link>, Nankai University, China</p></fn>
<fn fn-type="custom" custom-type="reviewed-by" id="fn0002"><p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/446674/overview">Xinmiao Fu</ext-link>, Fujian Normal University, China</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1138718/overview">Nitesh Priyadarshi</ext-link>, National Agri-Food Biotechnology Institute, India</p></fn>
</fn-group>
</back>
</article>